Research Alliance Corp IV

CIK: 2137777•Ticker: RACD

SPAC Overview

$75M
IPO Size
IPO
Current Status
2026
IPO Year

Timeline Progress

About

Research Alliance Corporation IV is a newly organized blank-check company seeking a business combination, with a stated focus on healthcare and healthcare-related companies, including drug development and commercialization, diagnostics, and healthcare technology and services.

Investment Focus

Healthcare, Biopharmaceuticals

Geographic Focus

United States

Embarc dashboard

What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.

  • Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
  • Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
  • The full 8-K lifecycle timeline, each event linked to its filing
  • Price history across the unit, share and warrant tickers
  • Follow it, and see it change on your watchlist
Open in the dashboard

SPAC Team

Underwriters

Extended Team Information

The team is affiliated with RA Capital Management, a life-sciences-focused investment firm. Its leadership includes healthcare investors and operators with experience across healthcare investing, biopharmaceutical companies, and prior SPACs, including the combination with POINT Biopharma.

Stock Performance

RACD
Trading Symbol
First Trade
July 13, 2026
$10.35
Current Price
October 1, 2026
$12.12
+17%

Key Information

IPO Date
July 13, 2026
State of Incorporation
E9
SIC
6770
SPAC Ticker
RACD